BETHANY EDOUARD: Open Payments
NPI 1881963106 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,555 in 85 payments from 23 companies in 2025. Trend: 2023 $1,784 · 2024 $1,673 · 2025 $1,555
Food & beverage: $1,555
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $221 |
| Sumitomo Pharma America, Inc. | 7 | $174 |
| Novo Nordisk Inc | 10 | $172 |
| GlaxoSmithKline, LLC. | 9 | $167 |
| PFIZER INC. | 6 | $113 |
| Phathom Pharmaceuticals, Inc. | 5 | $77 |
| Lilly USA, LLC | 3 | $69 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Astellas Pharma US Inc | 3 | $61 |
Products named: GEMTESA, TRELEGY ELLIPTA, EVENITY, OTEZLA, Rybelsus, VOQUEZNA, Ozempic, MOUNJARO.
Industry payments across FL — which companies pay providers there.
